← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2013-02-28

Drug application

FDA Application #

ANDA203052

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

LEVETIRACETAM ORAL

Active ingredients

LEVETIRACETAM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2013-02-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown